To investigate whether tumor‐induced PD‐L1 affects the functions of CD22 CAR‐T cells, we further generated a CD22 CAR/PD‐1ED construct expressing the PD‐1 ED that can lead to engagement of CAR‐T cells through PD‐1‐PD‐L1 ligation. Here, CD22 is linked to neoplasm.